AstraZeneca Pharma India Ltd. — Capital/Financing Update 2019

Jul 29, 2019

==> picture [28 x 42] intentionally omitted <==

AstraZeneca

July 29, 2019

==> picture [84 x 68] intentionally omitted <==

D1lnglng science lo p.aUtnll sine• 1979

The Manager - Listing

National Stock Exchange of India Ltd.

Exchange plaza, 5th Floor, Plot No. Cl I, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

The Manager - Listing

BSE Limited

Corporate Relationship Dept., I st Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 40000 I

Dear Sir(s),

Sub: Meeting of the Board of Directors of the Company to be held on Wednesday, August 7, 2019

Ref: Scrip Code - BSE: 506820, NSE: ASTRAZEN

This is to inform you that a meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Wednesday, August 7, 2019 inter alia, to:

1. consider and approve the Unaudited Financial Results of the Company for the quaiter ended June 30, 2019

2. consider declaration of an Interim Dividend to the equity shareholders of the Company for the financial year 2019-20

We would also like to inform you that the 'Trading Window' remains closed for all Designated Persons, from June 16, 2019 to August 9, 2019 (both days inclusive) in terms of AstraZeneca Pharma lndia Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition oflnsider Trading) Regulations 2015.

We request you to please take the same on record.

Thanking you,

Yours faithfully For AstraZeneca Phanna In

CORPORATE & REGO. OFFICE TEL : +91 80 6774 8000 FACTORY TEL : +91 80 6774 9000 AstraZeneca Pharma India Ltd. 12th Mile on Bellary Road P. B. No. 4525, Block N1, 12th Floor, FAX : +91 80 6774 8857 Venkatala, Kattigenahalli Village Manyata Embassy Business Park, CIN : L24231KA1979PLC003563 Yelahanka FAX : +91 80 2846 2208 Rachenahalli, Outer Ring Road, Bangalore - 560 063 +91 80 6774 9628 Bangalore - 560 045, INDIA WEB : www.astrazeneca.com/india INDIA